Adroit Market Research - Industry Insights
Global Vertebroplasty and Kyphoplasty Market, by Type (Vertebroplasty Devices, Kyphoplasty Devices), Region (North America, Europe, Asia Pacific, Middle East and Africa, Latin America), Global Forecast, 2018 to 2028
Nov 2020
Total Pages: 160
Choose License Type
The global Vertebroplasty and Kyphoplasty market was valued at USD 732.9 million in 2019 and is expected to grow at a CAGR of 5.6% over the forecast period.
Demand is expected to increase the incidence of spinal injuries related to car crashes and sports injuries. Moreover, the rise of the ageing population suffering from osteoporosis further encourages the growth of the vertebroplasty and kyphoplasty industry.
As per the International Osteoporosis Foundation estimates, osteoporosis causes more than 8.9 million fractures worldwide. A vertebral stress fracture, which affects about 7,50,000 people in the U.S. each year, mostly women, is a typical symptom of osteoporosis. Fractures in osteoporotic vertebral compression may lead to serious problems along with deformity and immobility. The obese and geriatric groups, the major cause of spinal or vertebral injuries, are more vulnerable to osteoporosis. Osteoporosis and low bone mass impact about 54.0 million elderly people in the U.S., according to statistics released by the National Osteoporosis Foundation (NOF). Fractures are associated with large causes of community health care costs and osteoporosis morbidity. Of all, one-quarter of osteoporotic fractures account for vertebral compression fractures.
Key players serving the global market include Stryker Corporation, Medtronic, IZI Medical Products, Globus Medical, Inc., Biopsybell, Laurane Medical, Teknimed, Merit Medical Systems, Inc., Zavation, among other prominent players.
Key segments of the global Vertebroplasty and Kyphoplasty market
Type Overview, 2018-2028 (USD Million)
- Vertebroplasty Devices
- Kyphoplasty Devices
Regional Overview, 2018-2028 (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Vertebroplasty and Kyphoplasty industry
- The overall segmentation of Vertebroplasty and Kyphoplasty market, especially key segments are thoroughly studied.
- Presence of major players and their wide Industry portfolio across developed countries is anticipated to further boost the growth of Vertebroplasty and Kyphoplasty market
What does the report include?
- The study on the global Vertebroplasty and Kyphoplasty market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global Vertebroplasty and Kyphoplasty market is suitable for all the players across the value chain including raw material suppliers, Vertebroplasty and Kyphoplasty providers, medical device manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global Vertebroplasty and Kyphoplasty market
Consultants, analysts, researchers, and academicians looking for insights shaping the global Vertebroplasty and Kyphoplasty market
In order to heal these injuries, vertebroplasty and kyphoplasty are widely used treatments. The treatment involves the infusion of plastic cement with (kyphoplasty) or without balloons (vertebroplasty) into the fractured bone. Under local anaesthesia and either CT or fluoroscopic supervision, all vertebroplasty and kyphoplasty procedures are done. There are, however, some complications related to cement leakage and cracking of the adjacent joint.
With conservative care, such as pain killers, bed rest, and braces, most VCFs are healed. However, a large number of non-resolved and enhanced VCF patients appear to experience chronic pain. If untreated, VCFs can lead to serious health effects and have a major effect on both the quality of life of the patient and on caregivers. There is also a rise in the need for vertebral prosthesis treatments to control pain and heal the fracture, since non-surgical treatment of these fractures has limited efficacy.
The global Vertebroplasty and Kyphoplasty market has been bifurcated based on type and region. In terms of type, the market is divided into Vertebroplasty Devices and Kyphoplasty Devices.
In 2019, kyphoplasty segment dominated the global market and is predicted to maintain its position over the study period. The specialised version of vertebroplasty is kyphoplasty which involves injecting a balloon into the injured vertebra accompanied by inflation of a balloon to create a cement filled cavity within the bone.
In the other side, vertebroplasty involves inserting cement directly into the broken bone without a balloon being utilised. Both treatments for vertebroplasty and kyphoplasty are minimally invasive and are carried out to treat fractures with vertebral compression in the spine. The treatment helps strengthen the broken bone and also tends to decrease the bone's deformity and regain vertebral height.
Based on regions, the global Vertebroplasty and Kyphoplasty market is segmented into North America, Europe, Asia Pacific, Central and South America and Middle East & Africa. Emerging markets such as APAC are giving companies major growth prospects in the demand for the Industry’s in coming years.
In 2019, North America dominated the global market. This is due to the rise in the prevalence of osteoporosis, together with the high demand in this area for minimally invasive to treat VCFs.. Europe followed the trail with market share of over 20% in 2019. Furthermore, Asia Pacific is anticipated to emerge as a lucrative market over the forecast period.
The global Vertebroplasty and Kyphoplasty market was valued at USD 732.9 million in 2019 and is expected to grow at a CAGR of 5.6% over the forecast period.
Demand is expected to increase the incidence of spinal injuries related to car crashes and sports injuries. Moreover, the rise of the ageing population suffering from osteoporosis further encourages the growth of the vertebroplasty and kyphoplasty industry.
As per the International Osteoporosis Foundation estimates, osteoporosis causes more than 8.9 million fractures worldwide. A vertebral stress fracture, which affects about 7,50,000 people in the U.S. each year, mostly women, is a typical symptom of osteoporosis. Fractures in osteoporotic vertebral compression may lead to serious problems along with deformity and immobility. The obese and geriatric groups, the major cause of spinal or vertebral injuries, are more vulnerable to osteoporosis. Osteoporosis and low bone mass impact about 54.0 million elderly people in the U.S., according to statistics released by the National Osteoporosis Foundation (NOF). Fractures are associated with large causes of community health care costs and osteoporosis morbidity. Of all, one-quarter of osteoporotic fractures account for vertebral compression fractures.
Key players serving the global market include Stryker Corporation, Medtronic, IZI Medical Products, Globus Medical, Inc., Biopsybell, Laurane Medical, Teknimed, Merit Medical Systems, Inc., Zavation, among other prominent players.
Key segments of the global Vertebroplasty and Kyphoplasty market
Type Overview, 2018-2028 (USD Million)
- Vertebroplasty Devices
- Kyphoplasty Devices
Regional Overview, 2018-2028 (USD Million)
- North America
- U.S.
- Canada
- Europe
- Germany
- United Kingdom
- France
- Spain
- Rest of Europe
- Asia Pacific
- China
- Japan
- India
- Rest of Asia Pacific
- Latin America
- Middle East & Africa
Reasons for the study
- The purpose of the study is to give an exhaustive outlook of the global Vertebroplasty and Kyphoplasty industry
- The overall segmentation of Vertebroplasty and Kyphoplasty market, especially key segments are thoroughly studied.
- Presence of major players and their wide Industry portfolio across developed countries is anticipated to further boost the growth of Vertebroplasty and Kyphoplasty market
What does the report include?
- The study on the global Vertebroplasty and Kyphoplasty market includes analysis of qualitative market indicators such as drivers, restraints, challenges and opportunities
- Additionally, the market competition has been evaluated using the Porter’s five forces analysis
- The study covers qualitative and quantitative analysis of the market segmented on the basis of type. Moreover, the study provides similar information for the key geographies.
- Actual market sizes and forecasts have been provided for all the considered segments
- The study includes the profiles of key players in the market with a significant global and/or regional presence
Who should buy this report?
- The report on the global Vertebroplasty and Kyphoplasty market is suitable for all the players across the value chain including raw material suppliers, Vertebroplasty and Kyphoplasty providers, medical device manufacturers, distributors, suppliers and retailers
- Venture capitalists and investors looking for more information on the future outlook of the global Vertebroplasty and Kyphoplasty market
Consultants, analysts, researchers, and academicians looking for insights shaping the global Vertebroplasty and Kyphoplasty market
Chapter 1. Introduction
1.1. Introduction to the Study
1.2. Market Definition and Scope
1.3. Units, Currency, Conversions and Years Considered
1.4. Key Stakeholders
1.5. Key Questions Answered
Chapter 2. Research Methodology
2.1. Introduction
2.2. Data Capture Sources
2.3. Primary Sources
2.4. Secondary Sources
2.5. Market Size Estimation
2.6. Market Forecast
2.7. Data Triangulation
2.8. Assumptions and Limitations
Chapter 3. Market Outlook
3.1. Introduction
3.2. Macroeconomic Indicators
3.3. Market Dynamics
3.3.1. Drivers
3.3.2. Restraints
3.3.3. Opportunities
3.3.4. Challenges
3.4. Porter’s Five Forces Analysis
3.5. COVID-19 Impact Analysis
Chapter 4. Global Vertebroplasty and Kyphoplasty Market by Type, 2018-2028 (USD Million)
4.1. Vertebroplasty Devices
4.2. Kyphoplasty Devices
Chapter 5. Global Vertebroplasty and Kyphoplasty Market by Region, 2018-2028 (USD Million)
5.1. North America
5.1.1. U.S.
5.1.2. Canada
5.2. Europe
5.2.1. Germany
5.2.2. UK
5.2.3. France
5.2.4. Spain
5.2.5. Rest of Europe
5.3. Asia Pacific
5.3.1. Japan
5.3.2. China
5.3.3. India
5.3.4. Rest of Asia Pacific
5.4. Central and South America
5.5. Middle East and Africa
Chapter 6. Company Profiles
6.1. Stryker Corporation
6.1.1. Overview
6.1.2. Product and Services Portfolio
6.1.3. Recent Initiatives
6.1.4. Company Financials
6.2. Medtronic
6.2.1. Overview
6.2.2. Product and Services Portfolio
6.2.3. Recent Initiatives
6.2.4. Company Financials
6.3. IZI Medical Products
6.3.1. Overview
6.3.2. Product and Services Portfolio
6.3.3. Recent Initiatives
6.3.4. Company Financials
6.4. Globus Medical, Inc.
6.4.1. Overview
6.4.2. Product and Services Portfolio
6.4.3. Recent Initiatives
6.4.4. Company Financials
6.5. Biopsybell
6.5.1. Overview
6.5.2. Product and Services Portfolio
6.5.3. Recent Initiatives
6.5.4. Company Financials
6.6. Laurane Medical
6.6.1. Overview
6.6.2. Product and Services Portfolio
6.6.3. Recent Initiatives
6.6.4. Company Financials
6.7. Teknimed
6.7.1. Overview
6.7.2. Product and Services Portfolio
6.7.3. Recent Initiatives
6.7.4. Company Financials
6.8. Merit Medical Systems, Inc.
6.8.1. Overview
6.8.2. Product and Services Portfolio
6.8.3. Recent Initiatives
6.8.4. Company Financials
6.9. Zavation
6.9.1. Overview
6.9.2. Product and Services Portfolio
6.9.3. Recent Initiatives
6.9.4. Company Financials
6.10. RONTIS
6.10.1. Overview
6.10.2. Product and Services Portfolio
6.10.3. Recent Initiatives
6.10.4. Company Financials
Chapter 7. Appendix
7.1. Primary Research Approach
7.1.1. Primary Interview Participants
7.1.2. Primary Interview Summary
7.2. Questionnaire
7.3. Related Reports
7.3.1. Published
7.3.2. Upcoming